France's renowned scientist and technical experts renew their presence at MEDLAB 2018

Dubai, United Arab Emirates December 20, 2017 -  17 French companies, including six new companies, will be taking part in the largest laboratory exhibition in Dubai, from 5 to 9 February 2018. France's range of in vitro diagnostic devices will be displayed over an area of 189 square meters, and will showcase the innovations that form the strategic foundations of the sector's development. Today, these major innovations are being used in nanotechnologies, genomics, proteomics and metabolomics. Thus, a substantial share of the market's turnover is invested in Research & Development.

 

In France, the market for IVD (in vitro diagnostic) medical devices for laboratory use is worth approximately €1,418 billion. There are around 200 specialist IVD companies in France, which directly employ about 1,000 people. The French in vitro diagnostics market is composed primarily of SMEs. Self-monitoring of blood glucose (SMBG) and in vitro diagnostics in laboratory settings account for 18% and 82% of the market, respectively. Public and private hospitals account for 40.5% of turnover, with the laboratory-based IVD market showing a slight decline.

 

Thanks to France's world-renowned scientific and technical expertise, French companies have the opportunity to compete in both the mid-range market (by offering good value for money) and in the high-end market. Working continuously to develop new solutions and improve their devices, French companies at MEDLAB will be unveiling their latest innovations in the reagents, analysers, medical and molecular biology, and haematology segments.

 

With the help of two regional partners — Lille Eurasanté and the Nouvelle Aquitaine region— the Pavilion run by Business France will showcase the latest French innovations at MEDLAB 2018. The technicity of these innovations is in line with the requirements of the highly demanding, fast-developing local market.